Logo

Roche

Advanced Cancer Outcomes Predicted Using Model Based on Circulating Tumor DNA Metrics

Researchers developed a ctDNA-based machine learning model for predicting metastatic non-small cell lung cancer response to immunotherapy and related survival outcomes.

In Brief This Week: PerkinElmer, Bruker, Calibre Scientific, Prenetics, T2 Biosystems, More

News items for the week of March 13, 2023.

Point32Health Expands Coverage of Foundation Medicine CDx Tests for Patients With Advanced Cancer

FoundationOne CDx and FoundationOne Liquid CDx comprehensive genomic profiling tests will be available to Point32Health patients with advanced solid tumors.

Roche, Janssen Expand Companion Diagnostic Collaboration

The new agreement allows the companies to collaborate with multiple technologies, including digital pathology and immunoassays.

Roche Diagnostics Revenues Essentially Flat in 2022

Molecular lab revenues fell 17 percent during the year, while core lab sales were up 3 percent and point-of-care revenues grew 15 percent. 

Jan 26, 2023

Foundation Medicine, Natera Launch Early Access for Clinical Personalized ctDNA Monitoring Test
Premium

Jan 11, 2023

JP Morgan Healthcare Conference, Day 2: Thermo Fisher, Agilent, Roche, Seer, More

Jan 10, 2023

Foundation Medicine, Karyopharm Therapeutics Partnering on Endometrial Cancer CDx

Jan 4, 2023

FDA Approves Foundation Medicine Blood Test as CDx for Rozlytrek

Dec 21, 2022

FDA Approves Foundation Medicine Assay as CDx for Certain NSCLC Therapies

Dec 16, 2022

People in the News at Personalis, Roche, Massive Bio, SeqLL, More

Dec 9, 2022

People in the News at Roche, Mammoth Biosciences, NeoGenomics, Molecular Assemblies, More

Nov 18, 2022

NeoGenomics, ImmunoGen Ink Testing Deal for Newly Approved Folate Receptor Drug

Nov 15, 2022

Roche Receives FDA Emergency Use Authorization for Cobas Monkeypox Test

Nov 1, 2022

Roche Cobas 5800, HIV-1 Assay Gets Premarket Approval from FDA

Oct 27, 2022

Biora Therapeutics Sells Cell-Free DNA Patents to Roche Diagnostics

Oct 24, 2022

Roche Obtains FDA 510(k) Clearance for COVID-19 PCR Test

Oct 20, 2022

Meet Ravgen, the Little-Known Company Rattling NIPTs Biggest Players in Court
Premium

Oct 18, 2022

Decline in Roche COVID-19 Product Demand Offset by Growth of Base Business
Premium

Oct 7, 2022

People in the News at MPI for Evolutionary Anthropology, Roche, TwinStrand, Quantum-Si, More

Sep 21, 2022

Roche Obtains CE Mark for Three Tests on New Cobas PCR Instrument

Sep 13, 2022

Roche Targeting Clinical Oncology Applications With Newly Launched Digital PCR Platform
Premium

Sep 12, 2022

Foundation Medicine, Relay Therapeutics to Develop FoundationOne CDx for FGFR2 Inhibitor

Aug 26, 2022

New Products Posted to GenomeWeb: Roche, OpGen, Immunexpress, More

Jul 21, 2022

Roche Diagnostics Revenues Rise 10 Percent in H1 as Company Prepares for COVID-19 Downturn
Premium

Breaking News
The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.